Glucuronidation converts clopidogrel to a strong time-dependent inhibitor of CYP2C8: a phase II metabolite as a perpetrator of drug-drug interactions.

A Tornio; AM Filppula; O Kailari; M Neuvonen; TH Nyrönen; T Tapaninen; PJ Neuvonen; Mikko Niemi; JT Backman

doi:10.1038/clpt.2014.141

Glucuronidation converts clopidogrel to a strong time-dependent inhibitor of CYP2C8: a phase II metabolite as a perpetrator of drug-drug interactions.

A Tornio, AM Filppula, O Kailari, M Neuvonen, TH Nyrönen, T Tapaninen, PJ Neuvonen, Mikko Niemi, JT Backman

Farmaci

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

120 Citeringar (Scopus)

Originalspråk	Engelska
Tidskrift	Clinical Pharmacology and Therapeutics
DOI	https://doi.org/10.1038/clpt.2014.141
Status	Publicerad - okt. 2014
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Åtkomst av dokument

10.1038/clpt.2014.141

Andra filer och länkar

http://europepmc.org/abstract/med/24971633

Citera det här

@article{37d431a0b02e4cf7acd7644240f36cc7,

title = "Glucuronidation converts clopidogrel to a strong time-dependent inhibitor of CYP2C8: a phase II metabolite as a perpetrator of drug-drug interactions.",

author = "A Tornio and AM Filppula and O Kailari and M Neuvonen and TH Nyr{\"o}nen and T Tapaninen and PJ Neuvonen and Mikko Niemi and JT Backman",

year = "2014",

month = oct,

doi = "10.1038/clpt.2014.141",

language = "English",

journal = "Clinical Pharmacology and Therapeutics",

issn = "0009-9236",

publisher = "American Society for Clinical Pharmacology and Therapeutics",

}

TY - JOUR

T1 - Glucuronidation converts clopidogrel to a strong time-dependent inhibitor of CYP2C8: a phase II metabolite as a perpetrator of drug-drug interactions.

AU - Tornio, A

AU - Filppula, AM

AU - Kailari, O

AU - Neuvonen, M

AU - Nyrönen, TH

AU - Tapaninen, T

AU - Neuvonen, PJ

AU - Niemi, Mikko

AU - Backman, JT

PY - 2014/10

Y1 - 2014/10

UR - http://europepmc.org/abstract/med/24971633

U2 - 10.1038/clpt.2014.141

DO - 10.1038/clpt.2014.141

M3 - Article

C2 - 24971633

SN - 0009-9236

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

ER -